Wales is focusing on accelerating the adoption of healthcare innovations to address pressures on its health and care systems, according to Cari-Anne Quinn, CEO of Life Sciences Hub Wales. The initiative aims to ensure that new products and solutions reach patients more effectively, supported by a connected health and care system and a growing life sciences sector.
The Medicines and Healthcare products Regulatory Agency (MHRA) is strengthening its engagement with innovators across all four UK nations, including Wales. This involves more direct interaction, such as new MHRA Liaison Days, to bring regulatory expertise closer to innovators and foster collaboration within the Welsh life sciences ecosystem.
Life Sciences Hub Wales plays a practical role in connecting healthcare challenges with organisations developing solutions. The goal is to move good ideas beyond pilot phases into wider use, with a focus on areas where innovation can have the greatest impact. Examples include a partnership with Macmillan Cancer Support to understand variations in cancer care and the Cardiff and Vale's Rapid Diagnosis Clinic, which reduced average referral-to-diagnosis times significantly.
The Welsh life sciences sector employs more than 13,000 people across approximately 300 companies, contributing around £3.6 billion in annual turnover. By making it easier for innovations to navigate the journey from evidence and regulation to adoption, Wales seeks to achieve better patient outcomes, more sustainable services, and growth in this high-value sector.